$BA (-1,81%) is the only stock in my portfolio that I deliberately classify not as a compounder, but as a turnaround bet. This is an important distinction because the usual benchmarks for capital allocation and ROIC simply do not apply to this company at the moment: Boeing hasn’t made a profit in years, and the question isn’t how good the business model is, but whether management can turn the business around before the balance sheet can no longer sustain it
Three segments. Commercial Airplanes builds commercial aircraft, primarily the 737 MAX family and the 787 Dreamliner, in a duopoly with Airbus—a market that structurally has the highest barriers to entry of any industry segment whatsoever, because certification, economies of scale, and customer switching costs are practically insurmountable. Defense, Space & Security supplies military aircraft, space systems, and defense programs, historically burdened by a series of fixed-price contracts from the past that shift the cost risk to Boeing rather than the customer. Global Services is the segment with the highest margins—maintenance, spare parts, and training systems—essentially an aftermarket business with the best economies of scale among the three divisions.
Consolidated revenue rose to 24.6 billion, an 8% increase from 22.75 billion in the same quarter of the previous year, driven by 171 commercial deliveries compared to 150 in the prior year—a 14% increase and the highest quarterly figure since 2018. Free cash flow turned positive at 631 million, compared with a negative 200 million in the same quarter of the previous year, marking the first positive result in over a year and significantly exceeding the cash burn expected by analysts. GAAP loss per share improved to minus $0.67 from minus $0.92, while the adjusted core loss improved to minus $0.76 from minus $1.24 in the prior-year period. Net debt decreased during the quarter from 47.2 to 45.9 billion, with a cash position of approximately 20 billion. The total backlog climbed to a record level of 715.3 billion, up from 682.2 billion at the end of 2025.
At the segment level, Commercial Airplanes saw revenue grow to 11.8 billion, while the operating loss narrowed from 557 to 322 million. The 737 production rate ramped up during the quarter from 42 to 47 units per month, and in July, a fourth production line—the North Line in Everett—began operations; the target remains 52 units per month, rising to 57 in the medium term, depending on supplier performance for wings and engines. On July 20, the FAA reinstated Boeing’s self-certification authority for newly built 737 MAX and 787 jets, a sign of regulatory confidence following years of heightened oversight since the MAX crisis. Defense, Space & Security grew 13% to 7.5 billion, but slipped into a narrow operating loss of $15 million due to a $280 million charge from the VC-25B program—the successor to Air Force One—compared with a profit of $110 million in the prior year. Global Services remained the reliable earnings anchor with an operating profit of 968 million and a 18.1% margin, albeit with a margin down from 19.9% in the prior year, due to the divestiture of the Digital Aviation Solutions division and a less favorable product mix.
Management guidance for 2026 is for free cash flow of $1 billion to $3 billion for the full year; in June, Fitch raised its outlook to positive, citing expectations of sustainable free cash flow exceeding $10 billion in the long term. That is the real bet: not a multiple on earnings that do not yet exist, but a bet on the speed at which the operating trajectory will return to that level. Valuation logic in the traditional sense—ROIC versus cost of capital—simply does not work here as long as the company remains loss-making on a consolidated basis.
The 787 program remains constrained by GE Aerospace engine deliveries, for which Boeing is working with GE on a remediation plan, though no end date has been set. Although the 777X program received FAA approval during the quarter for certification flights under TIA 4B, the first delivery is still not scheduled until 2027, following multiple delays since the original 2020 target. Fixed-price contracts in the defense segment represent a structural—not merely a one-time—problem; the VC-25B is the most recent example, but not the first; the KC-46 and T-7A faced similar challenges in the past. Net debt of just under 46 billion remains high enough—despite debt reduction efforts—that any further delay in production rate increases or certifications immediately jeopardizes cash flow guidance. In short: The thesis hinges on execution, not structure, and since the MAX crisis in 2019, Boeing’s execution has repeatedly fallen short of what was announced.
I view the position for what it is: a turnaround bet with limited weight in the portfolio, not a long-term compounder following the same pattern as Airbus, Safran, or MTU. The metric I track most closely isn’t quarterly profit, but the monthly 737 delivery rate relative to guidance, because it most directly shows whether the operational recovery is holding up or whether the supply chain is once again becoming a limiting factor.
How do you assess the balance between the risk associated with fixed-price contracts in the defense segment and the positive momentum in commercial delivery rates—does one outweigh the other for you?
